Abingworth LLP purchased a new stake in Innocoll Holdings PLC (NASDAQ:INNL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 537,235 shares of the specialty pharmaceutical company’s stock, valued at approximately $322,000. Innocoll accounts for about 0.2% of Abingworth LLP’s investment portfolio, making the stock its 18th largest holding. Abingworth LLP owned approximately 1.78% of Innocoll at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Goldman Sachs Group Inc. purchased a new position in Innocoll during the first quarter valued at approximately $224,000. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new position in Innocoll during the second quarter valued at approximately $802,000. Gamco Investors INC. ET AL purchased a new position in Innocoll during the second quarter valued at approximately $285,000. Tudor Investment Corp ET AL purchased a new position in Innocoll during the second quarter valued at approximately $868,000. Finally, GLG Partners LP purchased a new position in Innocoll during the second quarter valued at approximately $200,000. 34.16% of the stock is currently owned by institutional investors.
Innocoll Holdings PLC (NASDAQ INNL) opened at $2.35 on Wednesday. Innocoll Holdings PLC has a 12 month low of $0.53 and a 12 month high of $6.51. The company has a quick ratio of 0.86, a current ratio of 1.01 and a debt-to-equity ratio of -2.26.
COPYRIGHT VIOLATION WARNING: “Abingworth LLP Purchases Shares of 537,235 Innocoll Holdings PLC (INNL)” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://stocknewstimes.com/2017/12/06/abingworth-llp-purchases-shares-of-537235-innocoll-holdings-plc-innl.html.
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.